Document is current
Any future updates will be listed below
-
Authors
Baaijens, Jasmijn A. http://orcid.org/0000-0001-5661-0658
Zulli, Alessandro
Ott, Isabel M.
Nika, Ioanna
van der Lugt, Mart J.
Petrone, Mary E.
Alpert, Tara
Fauver, Joseph R.
Kalinich, Chaney C.
Vogels, Chantal B. F.
Breban, Mallery I.
Duvallet, Claire
McElroy, Kyle A.
Ghaeli, Newsha
Imakaev, Maxim
Mckenzie-Bennett, Malaika F.
Robison, Keith
Plocik, Alex
Schilling, Rebecca
Pierson, Martha
Littlefield, Rebecca
Spencer, Michelle L.
Simen, Birgitte B.
,
Altajar, Ahmad
Brito, Anderson F.
Watkins, Anne E.
Muyombwe, Anthony
Neal, Caleb
Liu, Chen
Castaldi, Christopher
Pearson, Claire
Peaper, David R.
Laszlo, Eva
Tikhonova, Irina R.
Razeq, Jafar
Rothman, Jessica E.
Wang, Jianhui
Bilguvar, Kaya
Niccolai, Linda
Wilson, Madeline S.
Anderson, Margaret L.
Landry, Marie L.
Adams, Mark D.
Hui, Pei
Downing, Randy
Earnest, Rebecca
Mane, Shrikant
Murphy, Steven
Hanage, William P.
Grubaugh, Nathan D.
Peccia, Jordan
Baym, Michael
-
Funding
Funding for this research was provided by:
Pew Charitable Trusts
David and Lucile Packard Foundation
National Institutes of Health (R35GM133700, U54GM088558)
Alfred P. Sloan Foundation
Mercatus Center at George Mason University
Centers for Disease Control and Prevention (75D30120C09570)
Yale University
- License Information
-
More Information
Article History
Received: 3 October 2021
Accepted: 25 October 2022
First Online: 8 November 2022
Declarations
:
: Not applicable.
: Not applicable.
: N.D.G. is an infectious diseases consultant for Tempus Labs. W.P.H. is a scientific advisory board member to Biobot Analytics and has received compensation for expert witness testimony on the expected course of the pandemic. N.G. is a co-founder of Biobot Analytics; C.D., K.A.M., and M.I. are employees of Biobot Analytics.
